British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma in situ (Bowen disease) 2022

The overall objective of the guideline is to provide up-to-date, evidence-based recommendations for the management of squamous cell carcinoma in situ (SCC in situ). The document aims to: offer an appraisal of all relevant literature up to 13th August 2021, focusing on any key developments; address important, practical clinical questions relating to the primary guideline objective; provide guideline recommendations and if appropriate research recommendations.

Automated summary

The guideline aims to provide evidence-based recommendations for managing squamous cell carcinoma in situ (SCC in situ). It evaluates relevant literature up to August 13, 2021, focusing on key developments, addresses important clinical questions, and provides guideline and research recommendations if appropriate.